[TIL (tumor-infiltrating lymphocytes): a new therapeutic approach for metastasizing kidney cancer].
Thiounn
N
N
Clinique urologique, Hôpital Cochin, Paris.
Peyret
C
C
Flam
T
T
Zerbib
M
M
Debré
B
B
D002478:Cells, Cultured; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D016246:Lymphocytes, Tumor-Infiltrating; D008285:Major Histocompatibility Complex / Q000276:immunology; D009362:Neoplasm Metastasis; D014407:Tumor Cells, Cultured
D007376:Interleukin-2
Les til: une nouvelle approche thérapeutique pour les cancers du rein métastasés.